CAS-87239-81-4

Teva’s fresh troubles over drug safety, Bollygarchs drug ‘price-gouging’ in Britain, Sun Pharma downsizes U.S. operations

This week’s Phispers takes you through pharmaceutical news from across the globe – from

Does speedy action by European agencies suggest revival of API production in the West?

Recently announced regulatory action against Indian and Chinese companies is creating a significant

Will data integrity concerns on clinical trials done at GVK Biosciences go beyond Europe?

 Over 700 commonly used generic medicines were recommended for suspension by the European Medic